Fortis Healthcare Limited has successfully completed its postal ballot process, with shareholders overwhelmingly approving three special resolutions related to the implementation of a new Employee Stock Option Scheme 2026. The voting concluded on March 18, 2026, demonstrating strong shareholder support for the company's employee incentive programs.

Postal Ballot Results Overview

The postal ballot process, conducted under SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, saw participation from 1,290 shareholders. CS Mukesh Kumar Agarwal served as the scrutinizer for the e-voting process, with KFin Technologies Limited providing the electronic voting platform. The record date for determining eligible voters was set as February 13, 2026.

Resolution-wise Voting Results

All three special resolutions were approved with requisite majority, showcasing strong shareholder confidence in the company's strategic initiatives.

Voting Participation Analysis

The postal ballot witnessed significant participation across different shareholder categories. The promoter and promoter group, holding 23,52,95,895 shares, voted unanimously in favor of all three resolutions through postal ballot mode. Public institutional investors showed strong support, with over 92% participation in the voting process.

Category-wise Participation Details

Employee Stock Option Scheme 2026 Details

The approved Employee Stock Option Scheme 2026 represents a comprehensive framework for employee incentivization across the Fortis Healthcare group. The scheme encompasses not only direct employees of Fortis Healthcare Limited but extends to eligible employees of subsidiary and associate companies, demonstrating the company's commitment to group-wide talent retention and motivation.

The third resolution, while receiving the lowest approval percentage at 87.58%, still secured substantial shareholder support for extending stock option benefits to associate company employees. This resolution faced relatively higher dissent, with 8,36,18,711 votes against, indicating some shareholder concerns about extending benefits beyond direct subsidiaries.

Regulatory Compliance and Process

The postal ballot was conducted in strict compliance with the Companies Act 2013, SEBI LODR Regulations 2015, and various MCA circulars. The company dispatched electronic notices to all eligible shareholders on February 16, 2026, and published advertisements in Financial Express (English) and Rozana Spokesman (Punjabi) on February 17, 2026.

The e-voting facility remained open until 5:00 PM on March 18, 2026, with votes being unblocked at 17:01 PM in the presence of independent witnesses. The comprehensive voting process included provisions for both electronic voting and physical postal ballot submissions, ensuring maximum shareholder accessibility and participation in the decision-making process. Company Secretary Satyendra Chauhan coordinated the entire process, with the scrutinizer report confirming all resolutions were deemed passed on March 18, 2026.

Fortis Healthcare Limited has announced that its composite scheme of merger by absorption involving five wholly-owned subsidiaries has become effective from March 1, 2026. The healthcare company informed the stock exchanges through a regulatory filing on March 2, 2026, confirming the completion of the merger process.

Merger Implementation Details

The company filed the certified copy of the Hon'ble National Company Law Tribunal (NCLT) order with the Registrar of Companies on March 1, 2026 at 3:00 P.M. (IST). The filing was completed by submitting Form INC-28, in accordance with the applicable provisions of the Companies Act, 2013.

Subsidiaries Involved in Merger

The composite scheme of arrangement involves the merger by absorption of five wholly-owned subsidiaries with their respective shareholders and creditors:

• Fortis Emergency Services Limited (FESL)
• Fortis Cancer Care Limited (FCC)
• Fortis Health Management (East) Limited (FHML)
• Birdie & Birdie Realtors Private Limited (B&B)
• Fortis Hospitals Limited (FHSL)

Regulatory Compliance

The announcement was made pursuant to Regulations 30 and 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This follows the company's earlier intimation dated January 16, 2026, regarding the merger proceedings.

The filing was signed by Satyendra Chauhan, Company Secretary & Compliance Officer, confirming the completion of all regulatory requirements for the merger scheme to take effect.